Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Viragen staged to begin U.S. clinical trials with Omniferon

Jan. 2, 2001

EMEA warns of reports of tuberculosis in patients treated with Remicade

Dec. 29, 2000

XTL Biopharmaceuticals updates hepatitis programs

Dec. 29, 2000

GlycoDesign and NRC establish infectious disease research program

Dec. 29, 2000

EU recommends approval of PegIntron/Rebetol combination for hepatitis C treatment

Dec. 27, 2000

Potential of tegaserod in GERD therapy indicated by recent clinical study findings

Dec. 22, 2000

Kyowa Hakko discusses work leading to development of therapeutically active 5-HT4 agonists

Dec. 21, 2000

Nucleoside analogue MIV-210 enters phase I for HBV treatment

Dec. 21, 2000

Phase I trials commence for Idun caspase inhibitor

Dec. 20, 2000

SB granted rights to new GERD therapy in all markets outside Korea

Dec. 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...